Deep vein thrombosis

Deep vein thrombosis
ICD-10	I80.2
ICD-9	453.40
DiseasesDB	3498
MeSH	D020246

Deep Vein Thrombosis Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Deep vein thrombosis from other Diseases
Epidemiology and Demographics
Risk Factors
Triggers
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Approach
Assessment of Clinical Probability and Risk Scores
Assessment of Probability of Subsequent VTE and Risk Scores
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Venography
CT
MRI
Other Imaging Findings
Treatment
Treatment Approach
Medical Therapy
IVC Filter
Invasive Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenario
Upper extremity DVT
Recurrence
Pregnancy
Trials
Landmark Trials
Case Studies
Case #1
Deep vein thrombosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Deep vein thrombosis
CDC on Deep vein thrombosis
Deep vein thrombosis in the news
Blogs on Deep vein thrombosis
Directions to Hospitals Treating Deep vein thrombosis
Risk calculators and risk factors for Deep vein thrombosis

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ujjwal Rastogi, MBBS [3]; Kashish Goel, M.D.; Assistant Editor(s)-In-Chief: Justine Cadet

For patient information page, click here

For main page on Venous thrombosis, click here

Synonym: DVT

Diagnosis

Diagnosis Approach | Pretest probability | History & Symptoms | Physical Examination | D-dimer | Ultrasound | Venography | CT scan venography | MRI | Other Imaging Findings

Specific situations

Treatment

• Treatment Approach
• Medical Therapy:

• Anticoagulation: Unfractionated Heparin | Low molecular weight heparin | Factor Xa inhibitor | Direct thrombin inhibitor | Warfarin
• Fibrinolysis: Catheter directed thrombolysis | Systemic thrombolysis

• Surgery
• Primary Prevention

• Secondary Prevention

Guidelines

ACCP Guidelines

Treatment Guidelines

Recommendations for initial approach for acute DVT of the leg | Recommendations for initial choice of treatment for acute DVT of the leg | Recommendations for duration of anticoagulant therapy | Recommendations for intensity of anticoagulant effect | Recommendations for treatment of isolated distal DVT | Recommendations for treatment of asymptomatic DVT of the leg | Recommendations for treatment in special situations | Recommendations for post-thrombotic syndrome

Thromboprophylaxis Guidelines

Recommendations for patients undergoing non-orthopedic surgery

Recommendations for patients undergoing nonorthopedic surgery : General surgery, GI surgery, Urological surgery and Gynecologic surgery, Bariatric surgery, Vascular surgery, and Plastic and Reconstructive surgery | Recommendations for Cardiac Surgery patients | Recommendations for Thoracic Surgery patients | Recommendations for Patients undergoing Craniotomy | Recommendations for Spinal Surgery Patients | Recommendations for Major Trauma Patients

Recommendations for patients undergoing Orthopedic surgery

Recommendations for patients undergoing undergoing THA, TKA, HFS | Recommendations for Isolated Lower-Leg Injuries Distal to the Knee | Recommendations for patients undergoing Knee arthroscopy

Recommendations for prevention of VTE in nonsurgical patients

Recommendations for Hospitalized Acutely Ill patients | Recommendations for Critically Ill patients | Recommendations for Cancer patients in an outpatient setting | Recommendations for Chronically Immobilized outpatients | Recommendations for Long-distance Travel | Recommendations for Asymptomatic Persons with Thrombophilia

AHA Guidelines

• Guidelines for duration of anticoagulant therapy

See also

• Venogram (medical)
• Thrombosis
• Venous thromboembolism
• Pulmonary embolism